Skip to main content
SpringerLink
Log in

Quality of Life, Cognition, and Social Cognition in Schizophrenia

  • Chapter
  • First Online:
Beyond Assessment of Quality of Life in Schizophrenia

Abstract

Nowadays, the main objective in treating patients with schizophrenia (SZ) is not only to attain and maintain symptomatic remission, in order to reach recovery, but also to avoid relapses and reach a level of personal and social functioning, as well as of quality of life (QoL), as near as possible to that of the general population (Hasan et al. 2013). In that sense, psychosocial functioning and QoL are increasingly recognized as important treatment outcomes in SZ (Juckel and Morosini 2008; Remington et al. 2010; Figueira and Brissos 2011).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Addington J, Addington D. Social and cognitive functioning in psychosis. Schizophr Res. 2008;99(1):176–81.

    Google Scholar 

  • Addington J, Saeedi H, Addington D. Influence of social perception and social knowledge on cognitive and social functioning in early psychosis. Br J Psychiatry. 2006;189(4):373–8.

    Article  PubMed  Google Scholar 

  • Aki H, Tomotake M, Kaneda Y, Iga J-I, Kinouchi S, Shibuya-Tayoshi S, Tayoshi S-Y, Motoki I, Moriguchi K, Sumitani S. Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia. Psychiatry Res. 2008;158(1):19–25.

    Article  PubMed  Google Scholar 

  • Alptekin K, Akvardar Y, Akdede BB, Dumlu K, Işık D, Pirinçci F, Yahssin S, Kitiş A. Is quality of life associated with cognitive impairment in schizophrenia? Prog Neuro-Psychopharmacol Biol Psychiatry. 2005;29(2):239–44.

    Article  Google Scholar 

  • American Psychiatric Association. Diagnostic and statistical manual-text revision. 4th ed., text rev. Washington, DC: Author; 2000.

    Google Scholar 

  • Baron‐Cohen S, Wheelwright S, Hill J, Raste Y, Plumb I. The “Reading the Mind in the Eyes” test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. J Child Psychol Psychiatry. 2001;42(2):241–51.

    Article  PubMed  Google Scholar 

  • Becchi A, Rucci P, Placentino A, Neri G, de Girolamo G. Quality of life in patients with schizophrenia—comparison of self-report and proxy assessments. Soc Psychiatry Psychiatr Epidemiol. 2004;39(5):397–401.

    Article  PubMed  Google Scholar 

  • Bell MD, Corbera S, Johannesen JK, Fiszdon JM, Wexler BE. Social cognitive impairments and negative symptoms in schizophrenia: are there subtypes with distinct functional correlates? Schizophr Bull. 2013;39(1):186–96.

    Article  PubMed  Google Scholar 

  • Bentall RP, Corcoran R, Howard R, Blackwood N, Kinderman P. Persecutory delusions: a review and theoretical integration. Clin Psychol Rev. 2001;21(8):1143–92.

    Article  CAS  PubMed  Google Scholar 

  • Bowie CR, Leung WW, Reichenberg A, McClure MM, Patterson TL, Heaton RK, Harvey PD. Predicting schizophrenia patients’ real-world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry. 2008;63(5):505–11.

    Article  PubMed  Google Scholar 

  • Boyer L, Aghababian V, Richieri R, Loundou A, Padovani R, Simeoni M, Auquier P, Lancon C. Insight into illness, neurocognition and quality of life in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2012;36(2):271–6.

    Article  CAS  Google Scholar 

  • Brekke JS, Kohrt B, Green MF. Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia. Schizophr Bull. 2001;27(4):697.

    Article  CAS  PubMed  Google Scholar 

  • Brekke JS, Hoe M, Long J, Green MF. How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Schizophr Bull. 2007;33(5):1247–56.

    Article  PubMed  PubMed Central  Google Scholar 

  • Brekke J, Hoe M, Green M. Neurocognitive change, functional change and service intensity during community-based psychosocial rehabilitation for schizophrenia. Psychol Med. 2009;39(10):1637–47.

    Article  CAS  PubMed  Google Scholar 

  • Brissos S, Dias VV, Soeiro-de-Souza MG, Balanzá-Martínez V, Kapczinski F. The impact of a history of psychotic symptoms on cognitive function in euthymic bipolar patients: a comparison with schizophrenic patients and healthy controls. Rev Bras Psiquiatr. 2011a;33(4):353–61.

    Article  PubMed  Google Scholar 

  • Brissos S, Dias VV, Balanzá-Martinez V, Carita AI, Figueira ML. Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance. Schizophr Res. 2011b;129(2):133–6.

    Article  PubMed  Google Scholar 

  • Brissos S, Dias VV, Carita AI, Martinez-Arán A. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates. Psychiatry Res. 2008;160(1):55–62.

    Google Scholar 

  • Brüne M. Emotion recognition, ‘theory of mind,’ and social behavior in schizophrenia. Psychiatry Res. 2005;133(2):135–47.

    Article  PubMed  Google Scholar 

  • Burton S. Symptom domains of schizophrenia: the role of atypical antipsychotic agents. J Psychopharmacol. 2006;20(6 suppl):6–19.

    Article  PubMed  Google Scholar 

  • Caqueo-Urízar A, Boyer L, Baumstarck K, Gilman SE. Subjective perceptions of cognitive deficits and their influences on quality of life among patients with schizophrenia. Qual Life Res. 2015;24(11):2753–60.

    Article  PubMed  Google Scholar 

  • Chino B, Nemoto T, Fujii C, Mizuno M. Subjective assessments of the quality of life, well‐being and self‐efficacy in patients with schizophrenia. Psychiatry Clin Neurosci. 2009;63(4):521–28.

    Google Scholar 

  • Chisholm D, Bhugra D. Sociocultural and economic aspects of quality of life measurement. Eur Psychiatry. 1997;12(4):210–5.

    Article  CAS  PubMed  Google Scholar 

  • Chue P. The relationship between patient satisfaction and treatment outcomes in schizophrenia. J Psychopharmacol. 2006;20(6 Suppl):38–56.

    Article  PubMed  Google Scholar 

  • Combs DR, Penn DL, Wicher M, Waldheter E. The Ambiguous Intentions Hostility Questionnaire (AIHQ): a new measure for evaluating hostile social-cognitive biases in paranoia. Cogn Neuropsychiatry. 2007;12(2):128–43.

    Article  PubMed  Google Scholar 

  • Corbera S, Wexler BE, Ikezawa S, Bell MD. Factor structure of social cognition in schizophrenia: is empathy preserved? Schizophr Res Treatment. 2013;2013:409205.

    Article  PubMed  PubMed Central  Google Scholar 

  • Corcoran R, Mercer G, Frith CD. Schizophrenia, symptomatology and social inference: investigating “theory of mind” in people with schizophrenia. Schizophr Res. 1995;17(1):5–13.

    Article  CAS  PubMed  Google Scholar 

  • Corrigan PW. The social perceptual deficits of schizophrenia. Psychiatry. 1997;60(4):309–26.

    CAS  PubMed  Google Scholar 

  • Couture SM, Penn DL, Roberts DL. The functional significance of social cognition in schizophrenia: a review. Schizophr Bull. 2006;32 Suppl 1:S44–63.

    Article  PubMed  PubMed Central  Google Scholar 

  • Couture SM, Granholm EL, Fish SC. A path model investigation of neurocognition, theory of mind, social competence, negative symptoms and real-world functioning in schizophrenia. Schizophr Res. 2011;125(2):152–60.

    Article  PubMed  Google Scholar 

  • Dickinson D, Coursey RD. Independence and overlap among neurocognitive correlates of community functioning in schizophrenia. Schizophr Res. 2002;56(1):161–70.

    Google Scholar 

  • Dickerson F, Ringel N, Parente F. Subjective quality of life in out‐patients with schizophrenia: clinical and utilization correlates. Acta Psychiatr Scand. 1998;98(2):124–7.

    Article  CAS  PubMed  Google Scholar 

  • Evans JD, Heaton RK, Paulsen JS, Palmer BW, Patterson T, Jeste DV. The relationship of neuropsychological abilities to specific domains of functional capacity in older schizophrenia patients. Biol Psychiatry. 2003;53(5):422–30.

    Article  PubMed  Google Scholar 

  • Figueira ML, Brissos S. Measuring psychosocial outcomes in schizophrenia patients. Curr Opin Psychiatry. 2011;24(2):91–9.

    PubMed  Google Scholar 

  • Fiske ST, Taylor SE. Social cognition. 2nd ed. New York: McGraw-Hill; 1991. p. 16–5.

    Google Scholar 

  • Fiszdon JM, Choi J, Goulet J, Bell MD. Temporal relationship between change in cognition and change in functioning in schizophrenia. Schizophr Res. 2008;105(1):105–13.

    Google Scholar 

  • Fitzgerald PB, Williams C, Corteling N, Filia S, Brewer K, Adams A, De Castella A, Rolfe T, Davey P, Kulkarni J. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatr Scand. 2001;103(5):387–92.

    Article  CAS  PubMed  Google Scholar 

  • Fujii DE, Wylie AM, Nathan JH. Neurocognition and long-term prediction of quality of life in outpatients with severe and persistent mental illness. Schizophrenia Res. 2004;69(1):67–73.

    Google Scholar 

  • Gallotti M, Frith CD. Social cognition in the we-mode. Trends Cogn Sci. 2013;17(4):160–5.

    Article  PubMed  Google Scholar 

  • Garrido G, Barrios M, Penadés R, Enríquez M, Garolera M, Aragay N, Pajares M, Vallès V, Delgado L, Alberni J. Computer-assisted cognitive remediation therapy: cognition, self-esteem and quality of life in schizophrenia. Schizophr Res. 2013;150(2):563–9.

    Article  PubMed  Google Scholar 

  • Gigaux J, Le Gall D, Jollant F, Lhuillier J, Richard-Devantoy S. Cognitive inhibition and quality of life in schizophrenia: a pilot study. Schizophr Res. 2013;143(2):297–300.

    Article  CAS  PubMed  Google Scholar 

  • Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 1996;153(3):321.

    Article  CAS  PubMed  Google Scholar 

  • Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”? Schizophr Bull. 2000;26(1):119.

    Article  CAS  PubMed  Google Scholar 

  • Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004;72(1):41–51.

    Article  PubMed  Google Scholar 

  • Green MF, Penn DL, Bentall R, Carpenter WT, Gaebel W, Gur RC, Kring AM, Park S, Silverstein SM, Heinssen R. Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophr Bull. 2008;34(6):1211–20.

    Article  PubMed  PubMed Central  Google Scholar 

  • Harvey PD, Keefe RS. Methods for delivering and evaluating the efficacy of cognitive enhancement. In: Cognitive Enhancement. Springer International Publishing; 2015. p. 5–25.

    Google Scholar 

  • Harvey PD, Velligan DI, Bellack AS. Performance-based measures of functional skills: usefulness in clinical treatment studies. Schizophr Bull. 2007;33(5):1138–48.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Möller H-J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J Biol Psychiatry. 2013;14(1):2–44.

    Article  PubMed  Google Scholar 

  • Hasson-Ohayon I, Avidan-Msika M, Mashiach-Eizenberg M, Kravetz S, Rozencwaig S, Shalev H, Lysaker PH. Metacognitive and social cognition approaches to understanding the impact of schizophrenia on social quality of life. Schizophr Res. 2014;161(2):386–91.

    PubMed  Google Scholar 

  • Hayhurst KP, Massie JA, Dunn G, Lewis SW, Drake RJ. Validity of subjective versus objective quality of life assessment in people with schizophrenia. BMC Psychiatry. 2014;14(1):365.

    Article  PubMed  PubMed Central  Google Scholar 

  • Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12(3):426.

    Article  CAS  PubMed  Google Scholar 

  • Heinrichs DW, Hanlon TE, Carpenter WT. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull. 1984;10(3):388.

    Article  CAS  PubMed  Google Scholar 

  • Herrman H, Hawthorne G, Thomas R. Quality of life assessment in people living with psychosis. Soc Psychiatry Psychiatr Epidemiol. 2002;37(11):510–8.

    Article  PubMed  Google Scholar 

  • Herman M. Neurocognitive functioning and quality of life among dually diagnosed and non‐substance abusing schizophrenia inpatients. Int J Ment Health Nurs. 2004;13(4):282–91.

    Google Scholar 

  • Hoe M, Nakagami E, Green M, Brekke J. The causal relationships between neurocognition, social cognition and functional outcome over time in schizophrenia: a latent difference score approach. Psychol Med. 2012;42(11):2287–99.

    Article  CAS  PubMed  Google Scholar 

  • Hofer A, Kemmler G, Eder U, Edlinger M, Hummer M, Fleischhacker WW. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. J Clin Psychiatry. 2004;65(7):932–9.

    Article  PubMed  Google Scholar 

  • Hofer A, Baumgartner S, Bodner T, Edlinger M, Hummer M, Kemmler G, Rettenbacher MA, Fleischhacker WW. Patient outcomes in schizophrenia II: the impact of cognition. Eur Psychiatry. 2005;20(5):395–402.

    Article  PubMed  Google Scholar 

  • Horan WP, Kern RS, Green MF, Penn DL. Social cognition training for individuals with schizophrenia: emerging evidence. Am J Psychiatr Rehabil. 2008;11(3):205–52.

    Article  Google Scholar 

  • Hoyle RH. Structural equation modeling: concepts, issues, and applications. Thousand Oaks: Sage Publications; 1995.

    Google Scholar 

  • Jakovljević M, Tomić Z, Maslov B, Skoko I. New image of psychiatry, mass media impact and public relations. Psychiatr Danub. 2010;22(2):145–8.

    PubMed  Google Scholar 

  • Juckel G, Morosini PL. The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia. Curr Opin Psychiatry. 2008;21(6):630–9.

    Article  PubMed  Google Scholar 

  • Karow A, Pajonk FG. Insight and quality of life in schizophrenia: recent findings and treatment implications. Curr Opin Psychiatry. 2006;19(6):637–41.

    Article  PubMed  Google Scholar 

  • Karow A, Wittmann L, Schöttle D, Schäfer I, Lambert M. The assessment of quality of life in clinical practice in patients with schizophrenia. Dialogues Clin Neurosci. 2014;16(2):185.

    PubMed  PubMed Central  Google Scholar 

  • Keefe R. The longitudinal course of cognitive impairment in schizophrenia: an examination of data from premorbid through posttreatment phases of illness. J Clin Psychiatry. 2013;75:8–13.

    Article  Google Scholar 

  • Keefe RS, Harvey PD. Cognitive impairment in schizophrenia. In: Novel antischizophrenia treatments. Springer Berlin Heidelberg; 2012. p. 11–37.

    Google Scholar 

  • Kilian R, Angermeyer MC. The effects of antipsychotic treatment on quality of life of schizophrenic patients under naturalistic treatment conditions: an application of random effect regression models and propensity scores in an observational prospective trial. Qual Life Res. 2005;14(5):1275–89.

    Article  PubMed  Google Scholar 

  • Kinderman P, Bentall RP. Causal attributions in paranoia and depression: internal, personal, and situational attributions for negative events. J Abnorm Psychol. 1997;106(2):341.

    Article  CAS  PubMed  Google Scholar 

  • Kitchen H, Rofail D, Heron L, Sacco P. Cognitive impairment associated with schizophrenia: a review of the humanistic burden. Adv Ther. 2012;29(2):148–62.

    Article  PubMed  Google Scholar 

  • Kohler CG, Martin E A, Kujawski E, Bilker W, Gur RE, Gur RC. No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia. Cogn Neuropsychiatry. 2007;12(5):412–21.

    Google Scholar 

  • Kret ME, Ploeger A. Emotion processing deficits: a liability spectrum providing insight into comorbidity of mental disorders. Neurosci Biobehav Rev. 2015;52:153–71.

    Article  PubMed  Google Scholar 

  • Kurtz MM. Neurocognition as a predictor of response to evidence-based psychosocial interventions in schizophrenia: what is the state of the evidence? Clin Psychol Rev. 2011;31(4):663–72.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kurtz MM, Tolman A. Neurocognition, insight into illness and subjective quality-of-life in schizophrenia: what is their relationship? Schizophr Res. 2011;127(1):157–62.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kurtz MM, Wexler BE, Fujimoto M, Shagan DS, Seltzer JC. Symptoms versus neurocognition as predictors of change in life skills in schizophrenia after outpatient rehabilitation. Schizophr Res. 2008;102(1):303–11.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kurtz MM, Bronfeld M, Rose J. Cognitive and social cognitive predictors of change in objective versus subjective quality-of-life in rehabilitation for schizophrenia. Psychiatry Res. 2012;200(2):102–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kurtz MM, Olfson RH, Rose J. Self-efficacy and functional status in schizophrenia: relationship to insight, cognition and negative symptoms. Schizophr Res. 2013;145(1):69–74.

    Article  PubMed  Google Scholar 

  • Lambert M, Schimmelmann BG, Karow A, Naber D. Subjective well-being and initial dysphoric reaction under antipsychotic drugs-concepts, measurement and clinical relevance. Pharmacopsychiatry. 2003;36:S181–90.

    Article  CAS  PubMed  Google Scholar 

  • Langdon R, Michie PT, Ward PB, McConaghy N, Catts SV, Coltheart M. Defective self and/or other mentalising in schizophrenia: a cognitive neuropsychological approach. Cogn Neuropsychiatry. 1997;2(3):167–93.

    Article  CAS  PubMed  Google Scholar 

  • Langdon R, Ward PB, Coltheart M. Reasoning anomalies associated with delusions in schizophrenia. Schizophr Bull. 2010;36(2):321–30.

    Article  PubMed  Google Scholar 

  • Lehman AF. Measures of quality of life among persons with severe and persistent mental disorders. Soc Psychiatry Psychiatr Epidemiol. 1996;31(2):78–88.

    Article  CAS  PubMed  Google Scholar 

  • Lehman AF. A quality of life interview for the chronically mentally ill. Eval Program Plann. 1988;11(1):51–62.

    Article  Google Scholar 

  • Lin C-H, Huang C-L, Chang Y-C, Chen P-W, Lin C-Y, Tsai GE, Lane H-Y. Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia. Schizophr Res. 2013;146(1):231–7.

    Article  PubMed  Google Scholar 

  • Lipkovich IA, Deberdt W, Csernansky JG, Sabbe B, Keefe RS, Kollack-Walker S. Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. BMC psychiatry. 2009;9(1):1.

    Google Scholar 

  • Lysaker PH, Carcione A, Dimaggio G, Johannesen J, Nicolò G, Procacci M, Semerari A. Metacognition amidst narratives of self and illness in schizophrenia: associations with neurocognition, symptoms, insight and quality of life. Acta Psychiatr Scand. 2005;112(1):64–71.

    Article  CAS  PubMed  Google Scholar 

  • Lysaker PH, Davis LW. Social function in schizophrenia and schizoaffective disorder: associations with personality, symptoms and neurocognition. Health Qual Life Outcomes. 2004;2(1):1.

    Google Scholar 

  • Maat A, Fett A-K, Derks E, Investigators G. Social cognition and quality of life in schizophrenia. Schizophr Res. 2012;137(1):212–8.

    Article  PubMed  Google Scholar 

  • Margariti M, Ploumpidis D, Economou M, Christodoulou GN, Papadimitriou GN. Quality of life in schizophrenia spectrum disorders: associations with insight and psychopathology. Psychiatry Res. 2015;225(3):695–701.

    Article  PubMed  Google Scholar 

  • Matsui M, Sumiyoshi T, Arai H, Higuchi Y, Kurachi M. Cognitive functioning related to quality of life in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008;32(1):280–7.

    Article  Google Scholar 

  • Mayer JD, Salovey P, Caruso DR, Sitarenios G. Emotional intelligence as a standard intelligence. Emotion (Washington, DC). 2001;1(3):232–42.

    Article  CAS  Google Scholar 

  • Mehta UM, Bhagyavathi HD, Thirthalli J, Kumar KJ, Gangadhar BN. Neurocognitive predictors of social cognition in remitted schizophrenia. Psychiatry Res. 2014;219(2):268–74. doi:10.1016/j.psychres.2014.05.055.

    Article  PubMed  Google Scholar 

  • Moncrieff J, Cohen D, Mason J. The subjective experience of taking antipsychotic medication: a content analysis of internet data. Acta Psychiatr Scand. 2009;120(2):102–11.

    Article  CAS  PubMed  Google Scholar 

  • Munton AG, Silvester J, Stratton P. Attributions in action: a practical approach to coding qualitative data. John Wiley & Sons Inc.; 1999.

    Google Scholar 

  • Nahum M, Fisher M, Loewy R, Poelke G, Ventura J, Nuechterlein KH, Hooker CI, Green MF, Merzenich MM, Vinogradov S. A novel, online social cognitive training program for young adults with schizophrenia: a pilot study. Schizophr Res Cogn. 2014;1(1):e11–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Narvaez JM, Twamley EW, McKibbin CL, Heaton RK, Patterson TL. Subjective and objective quality of life in schizophrenia. Schizophr Res. 2008;98(1):201–8.

    Article  PubMed  Google Scholar 

  • Norman RM, Malla AK, McLean T, Voruganti LP, Cortese L, McIntosh E, Cheng S, Rickwood A. The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale. Acta Psychiatr Scand. 2000;102(4):303–9.

    Article  CAS  PubMed  Google Scholar 

  • Nuechterlein KH, Subotnik KL, Green MF, Ventura J, Asarnow RF, Gitlin MJ, Yee CM, Gretchen-Doorly D, Mintz J. Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr Bull. 2011;37 Suppl 2:S33–40.

    Article  PubMed  PubMed Central  Google Scholar 

  • Papaioannou D, Brazier J, Parry G. How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review. Value Health. 2011;14(6):907–20.

    Article  PubMed  PubMed Central  Google Scholar 

  • Patterson TL, Goldman S, McKibbin CL, Hughs T, Jeste DV. UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull. 2001;27(2):235–45.

    Article  CAS  PubMed  Google Scholar 

  • Penn DL, Corrigan PW, Bentall RP, Racenstein J, Newman L. Social cognition in schizophrenia. Psychol Bull. 1997;121(1):114.

    Article  CAS  PubMed  Google Scholar 

  • Percudani M, Barbui C, Tansella M. Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia. Pharmacoeconomics. 2004;22(11):701–18.

    Article  CAS  PubMed  Google Scholar 

  • Priebe S, Katsakou C, Yeeles K, Amos T, Morriss R, Wang D, Wykes T. Predictors of clinical and social outcomes following involuntary hospital admission: a prospective observational study. Eur Arch Psychiatry Clin Neurosci. 2011;261(5):377–86.

    Article  PubMed  Google Scholar 

  • Prouteau A, Verdoux H, Briand C, Lesage A, Lalonde P, Nicole L, Reinharz D, Stip E. Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program. Schizophr Res. 2005;77(2):343–53.

    Article  PubMed  Google Scholar 

  • Reine G, Lancon C, Di Tucci S, Sapin C, Auquier P. Depression and subjective quality of life in chronic phase schizophrenic patients. Acta Psychiatr Scand. 2003;108(4):297–303.

    Article  CAS  PubMed  Google Scholar 

  • Remington G, Foussias G, Agid O. Progress in defining optimal treatment outcome in schizophrenia. CNS Drugs. 2010;24(1):9–20.

    Article  CAS  PubMed  Google Scholar 

  • Roberts DL, Penn DL. Social cognition and interaction training (SCIT) for outpatients with schizophrenia: a preliminary study. Psychiatry Res. 2009;166(2):141–7.

    Article  PubMed  Google Scholar 

  • Roberts DL, Penn DL, Labate D, Margolis SA, Sterne A. Transportability and feasibility of Social Cognition And Interaction Training (SCIT) in community settings. Behav Cogn Psychother. 2010;38(01):35–47.

    Article  PubMed  Google Scholar 

  • Rosenheck R, Leslie D, Keefe R, McEvoy J, Swartz M, Perkins D, Stroup S, Hsiao JK, Lieberman J. Barriers to employment for people with schizophrenia. Am J Psychiatry. 2006;163(3):411–7.

    Article  PubMed  Google Scholar 

  • Rosenthal R, Hall J, Archer D, DiMatteo M, Rogers P. The PONS test manual. New York: Irvington; 1979.

    Google Scholar 

  • Ruggeri M, Nose M, Bonetto C, Cristofalo D, Lasalvia A, Salvi G, Stefani B, Malchiodi F, Tansella M. Changes and predictors of change in objective and subjective quality of life Multiwave follow-up study in community psychiatric practice. Br J Psychiatry. 2005;187(2):121–30.

    Article  PubMed  Google Scholar 

  • Savilla K, Kettler L, Galletly C. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia. Aust N Z J Psychiatry. 2008;42(6):496–504.

    Article  PubMed  Google Scholar 

  • Schmidt SJ, Mueller DR, Roder V. Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: empirical review and new results by structural equation modeling. Schizophr Bull. 2011;37 Suppl 2:S41–54.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sergi MJ, Rassovsky Y, Widmark C, Reist C, Erhart S, Braff DL, Marder SR, Green MF. Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophr Res. 2007;90(1):316–24.

    Article  PubMed  Google Scholar 

  • Sota TL, Heinrichs RW. Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics. Compr Psychiatry. 2004;45(5):415–21.

    Article  PubMed  Google Scholar 

  • Stone VE, Baron-Cohen S, Knight RT. Frontal lobe contributions to theory of mind. J Cogn Neurosci. 1998;10(5):640–56.

    Article  CAS  PubMed  Google Scholar 

  • Subotnik KL, Nuechterlein KH, Green MF, Horan WP, Nienow TM, Ventura J, Nguyen AT. Neurocognitive and social cognitive correlates of formal thought disorder in schizophrenia patients. Schizophr Res. 2006;85(1):84–95.

    Article  PubMed  Google Scholar 

  • Tas C, Danaci AE, Cubukcuoglu Z, Brüne M. Impact of family involvement on social cognition training in clinically stable outpatients with schizophrenia—a randomized pilot study. Psychiatry Res. 2012;195(1):32–8.

    Article  PubMed  Google Scholar 

  • Tas C, Brown E, Cubukcuoglu Z, Aydemir O, Danaci AE, Brüne M. Towards an integrative approach to understanding quality of life in schizophrenia: the role of neurocognition, social cognition, and psychopathology. Compr Psychiatry. 2013;54(3):262–8.

    Article  PubMed  Google Scholar 

  • The WHOQOL Group. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403–9.

    Article  Google Scholar 

  • Tolman AW, Kurtz MM. Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation. Schizophr Bull. 2012;38(2):304–15.

    Article  PubMed  Google Scholar 

  • Ueoka Y, Tomotake M, Tanaka T, Kaneda Y, Taniguchi K, Nakataki M, Numata S, Tayoshi S, Yamauchi K, Sumitani S. Quality of life and cognitive dysfunction in people with schizophrenia. Progr Neuro-Psychopharmacol Biol Psychiatry. 2011;35(1):53–9.

    Article  Google Scholar 

  • Van Hooren S, Versmissen D, Janssen I, Myin-Germeys I, à Campo J, Mengelers R, Van Os J, Krabbendam L. Social cognition and neurocognition as independent domains in psychosis. Schizophr Res. 2008;103(1):257–65.

    Article  PubMed  Google Scholar 

  • Ventura J, Hellemann GS, Thames AD, Koellner V, Nuechterlein KH. Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophr Res. 2009;113(2):189–99.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ventura J, Wood RC, Jimenez AM, Hellemann GS. Neurocognition and symptoms identify links between facial recognition and emotion processing in schizophrenia: meta-analytic findings. Schizophr Res. 2013;151(1):78–84.

    Article  PubMed  PubMed Central  Google Scholar 

  • Voruganti L, Heslegrave R, Awad A, Seeman M. Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol Med. 1998;28(01):165–72.

    Article  CAS  PubMed  Google Scholar 

  • Voruganti L, Awad A, Parker G, Forrest C, Usmani Y, Fernando M, Senthilal S. Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine. Schizophr Res. 2007;96(1):146–55.

    Article  CAS  PubMed  Google Scholar 

  • Wegener S, Redoblado-Hodge MA, Wegener S, Redoblado-Hodge MA, Lucas S, Fitzgerald D, Harris A, Brennan J. Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Aust N Z J Psychiatry. 2005;39(6):487–92.

    Article  PubMed  Google Scholar 

  • Williams LM, Whitford TJ, Flynn G, Wong W, Liddell BJ, Silverstein S, Gordon E. General and social cognition in first episode schizophrenia: identification of separable factors and prediction of functional outcome using the IntegNeuro test battery. Schizophr Res. 2008;99(1):182–191.

    Google Scholar 

  • Woon P, Chia MY, Chan WY, Sim K. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2010;34(3):463–8.

    Article  Google Scholar 

  • Woonings FM, Appelo MT, Kluiter H, Slooff CJ, van den Bosch RJ. Learning (potential) and social functioning in schizophrenia. Schizophr Res. 2003;59(2):287–96.

    Article  PubMed  Google Scholar 

  • Wykes T, Reeder C, Landau S, Everitt B, Knapp M, Patel A, Romeo R. Cognitive remediation therapy in schizophrenia. Br J Psychiatry. 2007;190(5):421–7.

    Article  PubMed  Google Scholar 

  • Yamauchi K, Aki H, Tomotake M, Iga JI, Numata S, Motoki I, Izaki Y, Tayoshi S, Kinouchi S, Sumitani S. Predictors of subjective and objective quality of life in outpatients with schizophrenia. Psychiatry Clin Neurosci. 2008;62(4):404–11.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Centro Hospitalar Psiquiátrico de Lisboa (Lisbon’s Psychiatric Hospitalar Centre), Lisbon, Portugal

    Sofia Brissos MD & Guilherme Pereira MD

  2. Teaching Unit of Psychiatry, Department of Medicine, School of Medicine, La Fe University and Polytechnic Hospital, University of Valencia, CIBERSAM, Valencia, Spain

    Vicent Balanzá-Martinez MD, PhD

Authors
  1. Sofia Brissos MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guilherme Pereira MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vicent Balanzá-Martinez MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sofia Brissos MD .

Editor information

Editors and Affiliations

  1. Psychiatry, University of Toronto, Toronto, Ontario, Canada

    A. George Awad

  2. Department of Psychiatry, University of Western Ontario, London, Ontario, Canada

    Lakshmi N.P. Voruganti

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Brissos, S., Pereira, G., Balanzá-Martinez, V. (2016). Quality of Life, Cognition, and Social Cognition in Schizophrenia. In: Awad, A., Voruganti, L. (eds) Beyond Assessment of Quality of Life in Schizophrenia. Adis, Cham. https://doi.org/10.1007/978-3-319-30061-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30061-0_3

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-30059-7

  • Online ISBN: 978-3-319-30061-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation